A recent study reported that CD109 expression blocked the TGF-β-elicited EMT process [17]; however, CD109 overexpression was shown to alleviate TGF-β-mediated suppression of cell growth in oral squamous cell carcinoma [5]. The gene discussed is CD109; the disease is oral cavity squamous cell carcinoma.